Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

Purpose of this funding opportunity announcement is to encourage collaborations- between life science and physical science- that: 1) apply a multidisciplinary bioengineering approach to solve biomedical problems; and 2) develop, integrate, optimize, validate, translate or accelerate adoption of promising tools, methods and techniques: a) that fulfill an unmet need and address specific research or clinical problem in basic, translational, and/or clinical science and practice, b) capable of enhancing our understanding of health and disease, and/or c) improve practice of medicine. Applications may propose design-directed, developmental, discovery-driven, or hypothesis-driven research, and this FOA is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science.

Companion FOA: PAR-22-243, Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Deadlines:

  • Letter of Intent: 30 days prior to application due date.
  • R01 Deadlines: October 31, 2022, then standard dates: Feb. 5, Jun. 5, Oct. 5.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7.

PAR-22-242 Expiration Date: September 08, 2025

 

Eligibility

Faculty

Category

Engineering and Physical Sciences
Environmental & Life Sciences
Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 5, 2023